These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 909221

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [A controlled comparison of daily and intermittent triple drug regimens (SM-INH-EB) in original treatment. Report of the 16th series of Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1974 Aug; 49(8):247-52. PubMed ID: 4427402
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)].
    Kekkaku; 1979 Jan; 54(1):51-61. PubMed ID: 107362
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T.
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract] [Full Text] [Related]

  • 9. [Intensive chemotherapy of pulmonary tuberculosis].
    Shesterina MV, Gavrilenko VS, Tarasova EF, Sokolova GV, Tregubov IuG.
    Probl Tuberk; 1980 Jul; (7):20-22. PubMed ID: 6997865
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Intermittent chemotherapy of pulmonary tuberculosis with rifampicin and ethambutol].
    Virsik K, Kruty R, Matula F, Badalik L.
    Probl Tuberk; 1978 Oct; (10):28-30. PubMed ID: 714902
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A controlled trial of 6-month and 12-month regimens after negative conversion of sputum in the original treatment of pulmonary tuberculosis. Report of the 21st series of controlled trials of chemotherapy. Cooperative Study Unit of Chemotherapy of Tuberculosis of National Sanatoria in Japan (CSUCTNS)].
    Kekkaku; 1984 Feb; 59(2):81-9. PubMed ID: 6379258
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Is the combination of INH and RFP always bactericidal? An observation in programme condition--report of the B series of 20th Controlled Trial of Chemotherapy (author's transl)].
    Kekkaku; 1980 Apr; 55(4):207-14. PubMed ID: 6993746
    [No Abstract] [Full Text] [Related]

  • 20. [A study on short-course chemotherapy for pulmonary tuberculosis (Report 2)--6--9 month short-course chemotherapy (author's transl)].
    Yamamoto K, Aizawa H, Inoue I, Sasaoka M, Suzuki T, Kameda K, Yamaguchi W, Shimada M.
    Kekkaku; 1979 Sep; 54(9):467-72. PubMed ID: 502154
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.